Australia markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
36.26-0.76 (-2.05%)
At close: 04:00PM EDT
36.37 +0.11 (+0.30%)
After hours: 05:41PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5576
Avg. Estimate-0.69-0.71-3.01-3.09
Low estimate-0.75-0.76-3.55-3.93
High estimate-0.65-0.67-2.75-1.76
Year ago EPS-0.62-0.65-2.92-3.01
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4476
Avg. Estimate920k920k3.15M2.76M
Low estimateN/AN/AN/AN/A
High estimate1.6M1.6M6.5M6.5M
Year ago sales967k268k6.88M3.15M
Sales growth (year/est)-4.90%243.30%-54.20%-12.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.63-0.67-0.68-0.74
Actual EPS-0.62-0.65-0.81-0.83
Difference0.010.02-0.13-0.09
Surprise %1.60%3.00%-19.10%-12.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.69-0.71-3.01-3.09
7 days ago-0.69-0.71-3.01-3.09
30 days ago-0.69-0.71-3.01-3.09
60 days ago-0.74-0.74-3.1-3.2
90 days ago-0.75-0.75-3.09-3.23
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLDXIndustrySector(s)S&P 500
Current qtr.-11.30%N/AN/AN/A
Next qtr.-9.20%N/AN/AN/A
Current year-3.10%N/AN/AN/A
Next year-2.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A